Nyxoah S.A.
Status: Publicly traded
Direct answer
Nyxoah S.A. is publicly traded on NASDAQ under the ticker NYXH.
Nyxoah SA, a medical technology company, develops and commercializes solutions to treat obstructive sleep apnea (OSA). The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, minimally invasive, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah SA was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
Can you invest in Nyxoah S.A.?
Yes. Nyxoah S.A. trades publicly on NASDAQ as NYXH.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Detailed equity research is provided by MarketSnap.